TOKYO, March 13, 2025 — MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM” or the “Company”) has announced that Yasuhiro Hayami, Chief Business Officer of its subsidiary, MEDIROM Mother Labs Inc. (“Mother Labs”), has made a further investment in Mother Labs’ Series A financing, valuing the company at JPY9 billion (approximately US$60 million as of March 13, 2025) before the investment. This follows Mr. Hayami’s initial investment in the Series A financing made in December 2024. As a dedicated senior executive, Mr. Hayami shares MEDIROM’s core values, vision, and belief in the company’s future growth.

Background of Executive Officer

Yasuhiro Hayami
Chief Business Officer (CBO), MEDIROM MOTHER Labs Inc.

Career Summary

  • 1996 Founded INIT Co., Ltd. and served as Representative Director
  • 2004 Became Executive Officer of transcosmos inc.
  • 2014 Established Wise, Inc.
  • 2024 Appointed Chairman of the Board of MEDIROM Rehab Solutions, Inc.
  • 2024 Appointed Chief Business Officer of MEDIROM MOTHER Labs

No Offer or Solicitation

This press release and its contents do not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction.

Forward-Looking Statements Regarding MEDIROM

This press release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. These statements may include expectations or estimates regarding MEDIROM’s potential operational and financial results, business strategies, market opportunities, competitive positioning, industry outlook, and growth prospects. Words such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” and similar expressions identify forward-looking statements, which reflect uncertainty about future events or outcomes. These statements concern future events or MEDIROM’s future financial performance and are subject to known and unknown risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied. Readers are cautioned not to place undue reliance on these statements, as they involve risks, uncertainties, and other factors, some of which are beyond MEDIROM’s control and could affect actual results. These factors relate to MEDIROM’s operations, financial performance, growth strategy, and liquidity.

More information about these risks and other factors that could impact MEDIROM’s business, reputation, financial results, and stock price can be found in MEDIROM’s filings with the SEC, including the “Risk Factors” and “Operating and Financial Review and Prospects” sections of its most recent Form 20-F report and subsequent filings, available on the SEC website (www.sec.gov). MEDIROM disclaims any obligation to update or revise these forward-looking statements, even if new information becomes available in the future.

ABOUT MEDIROM MOTHER Labs Inc.

Mother Labs, a subsidiary of MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM), is focused on the health-tech industry. Its main activities include the “Specific Health Guidance Program” offered through the “Lav” health application, along with the development and sale of the 24/7 recharge-free MOTHER Bracelet smart tracker. Utilizing the unique features of the MOTHER Bracelet, Mother Labs provides tailored health management solutions for various sectors, including caregiving, logistics, and manufacturing.

MEDIROM Healthcare Technologies Inc.
NASDAQ Symbol: MRM
Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, Japan
Web https://medirom.co.jp/en
Contact: ir@medirom.co.jp

MEDIROM MOTHER Labs Inc.
Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, Japan

MOTHER Bracelet

The MOTHER Bracelet is the world’s first* 24/7 smart tracker that requires no recharging. It uses innovative technology from a Silicon Valley company to generate power from temperature differences between the body and the surrounding air. The recharge-free design prevents data loss when the device is not worn for charging. The MOTHER Bracelet tracks five key metrics: heart rate, calories burned, body surface temperature, step count, and sleep.
Official Website: https://mother-bracelet.com

* According to ESP Research Institute (July 3, 2021), it is the first activity tracker to use the Seebeck effect for power generation and eliminate the need for recharging.

“`